Home/Filings/4/0001181431-06-004122
4//SEC Filing

KELLY MICHAEL GERALD 4

Accession 0001181431-06-004122

CIK 0001118361other

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 7:16 PM ET

Size

7.4 KB

Accession

0001181431-06-004122

Insider Transaction Report

Form 4
Period: 2006-01-16
KELLY MICHAEL GERALD
VP, Drug Discovery
Transactions
  • Sale

    Common Stock

    2006-01-17$18.18/sh1,000$18,18040,966 total
  • Award

    Stock Option (Right to Buy)

    2006-01-16+150,000150,000 total
    Exercise: $18.18Exp: 2016-01-15Common Stock (150,000 underlying)
Footnotes (4)
  • [F1]Disposition of securities made pursuant to a 10b5-1 plan adopted by Dr. Kelly on March 17, 2005.
  • [F2]Includes 166 shares acquired through 401k employer match contribution.
  • [F3]The option becomes vested and exercisable in substantially equal monthly installments over the 4-year period following the date of grant.
  • [F4]not applicable

Issuer

RENOVIS INC

CIK 0001118361

Entity typeother

Related Parties

1
  • filerCIK 0001278455

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 7:16 PM ET
Size
7.4 KB